Early Black Friday: Up to 50% Off Today

Shop Now

Scientific Clinical Studies

Peer-reviewed research behind the light and ingredients in Groomie products.

Category

Male facial rejuvenation using a combination 633, 830, and 1072 nm LED face mask

By Mineroff

"The participants reported overall favorable results and improvements in all individual categories, were satisfied with the treatment, and would recommend the product to others. The participants perceived the greatest improvement in fine lines and wrinkles, skin texture, and youthful appearance. Photographic digital analysis demonstrated favorable improvements in wrinkles, UV spots, brown spots, pores, and porphyrins."

Read more: Male facial rejuvenation using a combination 633, 830, and 1072 nm LED face mask (opens in a new tab)

Efficacy of Home-Use Light-Emitting Diode Device at 637 and 854-nm for Facial Rejuvenation: A Split-Face Pilot Study

By Ng

"All 24 subjects completed the study and attended all follow-up. Skin elasticity was significantly higher in the LED group compared to the control during the 6- and 8-week follow-up (p < 0.05). In the LED group, an image of the treated skin captured using Visioscan® showed improvement of the skin texture at 8-week follow-up.

Majority of the subjects in the LED group scored good improvement on all follow-ups (37.5%, 41.7%, 58.3% and 62.5%) when compared to the baseline. No adverse reactions or pain were recorded in the study."

Comment: Only 2 of the 10 statistical intergroup tests showed significant difference. without correction for multiple testing (eg. Bonferroni).

Read more: Efficacy of Home-Use Light-Emitting Diode Device at 637 and 854-nm for Facial Rejuvenation: A Split-Face Pilot Study (opens in a new tab)

Shining a (blue) light on hair follicle chronobiology and photobiomodulation

By Paus R

"In their study, Buscone et al.44 (2021) now report that the exposure of human scalp HFs to blue light (453 nm) leads to an intrafollicular accumulation of CRY1 protein. This CRY1 stimulation prolongs anagen, while CRY1 silencing promotes catagen development ex vivo. The authors also find CRY1 protein to be prominently expressed in human scalp HFs during anagen, notably including in epithelial stem/progenitor cells.44 This is in line with the concept that the previously reported hair growth stimulation by blue light48 is mediated, at least in part, by CRY1—inviting the direct targeting of CRY1 expression/activity in the future management of both, hair loss (alopecia, effluvium) and unwanted hair growth (hirsutism, hypertrichosis)."

Read more: Shining a (blue) light on hair follicle chronobiology and photobiomodulation (opens in a new tab)

Cryptochrome 1 is modulated by blue light in human keratinocytes and exerts positive impact on human hair growth

By Buscone

"Here, we show that 453 nm blue light induces cryptochrome 1 (CRY1) accumulation in human keratinocytes and the hair follicle. CRY1 is prominently expressed in the human anagen hair follicle, including epithelial stem cells. Specific silencing of CRY1 promotes catagen, while stimulation of CRY1 by KL001 prolongs anagen ex vivo by altering the expression of genes involved in apoptosis and proliferation."

Read more: Cryptochrome 1 is modulated by blue light in human keratinocytes and exerts positive impact on human hair growth (opens in a new tab)

The 675-nm wavelength for treating facial melasma

By Coricciati

"Our research shows that individuals with Fitzpatrick phototypes II to III can treat facial melasma with the 675-nm laser source system without risk. Due to its interaction with melanin, collagen and haemoglobin chromophores, as well as its excellent capacity to penetrate tissues with less heating, this system is promising in the treatment of pigmentary and vascular illnesses such as melasma. The great success of the technology we used came from the reduced levels of inflammation produced after the treatments and the low energy level implied."

Read more: The 675-nm wavelength for treating facial melasma (opens in a new tab)

Role of Low-Level Light Therapy (LLLT) in Androgenetic Alopecia

By Pillai & Mysore

"Fifteen studies were found to be strongly relevant and were analyzed. Studies have shown that LLLT stimulated hair growth in both men and women. Studies with largest randomized controlled trials demonstrated statistically significant hair regrowth by terminal hair count in both males and females. One study also showed that LLLT and minoxidil had similar efficacy in hair growth and that combination therapy was even more effective."

Read more: Role of Low-Level Light Therapy (LLLT) in Androgenetic Alopecia (opens in a new tab)

LED photoprevention: reduced MED response following multiple LED exposures.

By Barolet & Boucher

"Reduction of erythema was considered significant when erythema was reduced by >50% on the LED-treated side as opposed to CONTROL side. A significant LED treatment reduction in UV-B induced erythema reaction was observed in at least one occasion in 85% of subjects, including patients suffering from PLE. Moreover, there was evidence of a dose-related pattern in results. Finally, a sun protection factor SPF-15-like effect and a reduction in post-inflammatory hyperpigmentation were observed on the LED pre-treated side."

Read more: LED photoprevention: reduced MED response following multiple LED exposures. (opens in a new tab)

The Use of a Light-Emitting Diode Device for Neck Rejuvenation and Its Safety on Thyroid Glands

By Lee

"Evaluation using the Lemperle wrinkle scale and global improvement scales by both investigators and subjects showed significant improvement after 16 weeks of daily application, as well as 8 weeks after discontinuation. Biophysical parameters, such as hydration, elasticity, and density, also showed significant improvements."

Read more: The Use of a Light-Emitting Diode Device for Neck Rejuvenation and Its Safety on Thyroid Glands (opens in a new tab)

Results: 15